← All trials

NCT05271916

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Apr 1, 2022
Primary completion
Jan 1, 2025
Completion date
May 1, 2027
First posted
Mar 9, 2022
Last posted
Mar 9, 2022
Enrollment
140
Arms / groups
2 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.